Primary coronary artery stenosis causes symptomatic ischemic heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients aged 18-80 years; (2) According to the guidelines for patients with symptomatic coronary artery disease treated with DES (first time); (3) There are 1 or more coronary artery lesions with diameter stenosis = 50%, among which 1-2 are suitable for implantation of 2.5*38, 2.75*38, 3.0*38, 3.5*38, or 4.0*38 stents; (4) Patient who willing to participate in the study and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients who are expected to implant more than 3 stents in total; (2) Women who are pregnant or breastfeeding; (3) Patients who are not expected to adapt to antiplatelet and/or anticoagulant therapy; (4) This product is not suitable for patients who are allergic to rapamycin or 316L stainless steel, polyglycolide lactide polymer; (5) Patients whose lesions are thought to hinder the complete expansion of the angioplasty balloon; (6) Patients who have undergone transplant surgery; (7) The patient was also involved in other devices or drugs or other studies and had not yet reached the end of the study; (8) Patients undergoing elective clopidogrel surgery must be discontinued during normal planned clopidogrel use; (9) The researchers believe that patients are not suitable for stenting and can not complete follow-up, such as patients with advanced malignant tumors, severe liver and kidney disease, stroke patients, severe infections and severe hematological diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Target lesion failure rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Instrument success rate;Surgery success rate;Loss of late lumen within target segment;Percentage of narrow diameter; | — |
Countries
China
Contacts
Inner Mongolia Autonomous Region People's Hospital